Nabilone

CAS 51022-71-0 2 current recordsSmall Molecule

Who holds supplier records for Nabilone? 2 organisations hold a current record for Nabilone: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Germany (1) and United States (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Nabilone: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/nabilone

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nabilone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Nabilone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Nabilone is a synthetic cannabinoid that mimics some of the effects of natural cannabis. It is used in the treatment of severe nausea and vomiting caused by chemotherapy and as an adjunct in the management of chronic pain.

Chemical identity

IUPAC name
(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one
Canonical SMILES
CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=O)CC[C@H]3C(OC2=C1)(C)C)O
InChIKey
GECBBEABIDMGGL-RTBURBONSA-N
Synonyms
Cesamet API, cesamet, cpd 109514, cpd-109514

Therapeutic areas

Nausea and VomitingAppetite Stimulation

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nabilone?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Nabilone: FINETECH PHARMACEUTICAL LTD (Germany) and PURISYS LLC (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nabilone Drug Master Files are active?

FINETECH PHARMACEUTICAL LTD (DMF 31946) and PURISYS LLC (DMF 35408). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Nabilone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nabilone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.